Apyx Medical Corporation Share Price
Equities
APYX
US03837C1062
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.45 USD | -2.03% | +9.85% | -44.66% |
05/04 | Archon Capital Management Engages with Apyx Medical Corporation | CI |
01/04 | Stavros G. Vizirgianakis Engages in Discussions with Apyx Medical Corporation | CI |
Sales 2024 * | 49.94M 4.16B | Sales 2025 * | 54.52M 4.55B | Capitalization | 50.23M 4.19B |
---|---|---|---|---|---|
Net income 2024 * | -27M -2.25B | Net income 2025 * | -25M -2.08B | EV / Sales 2024 * | 1.01 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.92 x |
P/E ratio 2024 * |
-1.86
x | P/E ratio 2025 * |
-2.08
x | Employees | 252 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.08% |
Latest transcript on Apyx Medical Corporation
1 day | -2.03% | ||
1 week | +9.85% | ||
Current month | +6.62% | ||
1 month | +13.28% | ||
3 months | -36.12% | ||
6 months | -40.57% | ||
Current year | -44.66% |
Managers | Title | Age | Since |
---|---|---|---|
Charles Goodwin
CEO | Chief Executive Officer | 58 | 15/17/15 |
Andrew Makrides
FOU | Founder | 82 | 01/78/01 |
Matthew Hill
DFI | Director of Finance/CFO | 56 | 04/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Makrides
FOU | Founder | 82 | 01/78/01 |
Lawrence Waldman
BRD | Director/Board Member | 77 | 15/11/15 |
Craig Swandal
BRD | Director/Board Member | 63 | 09/18/09 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 1.45 | -2.03% | 58,368 |
25/24/25 | 1.48 | -1.33% | 68,488 |
24/24/24 | 1.5 | +13.64% | 187,605 |
23/24/23 | 1.32 | +4.76% | 54,670 |
22/24/22 | 1.26 | -4.55% | 77,365 |
Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.66% | 50.23M | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- APYX Stock